|
Volumn 22, Issue 21, 2012, Pages 6750-6755
|
Part II. Development of novel colchicine-derived immunosuppressants with improved pharmacokinetic properties
|
Author keywords
Autoimmune disease; Colchicine; Cyclosporine A (CsA); Immunosuppressant; Mixed lymphocyte reaction (MLR); Rejection of organ transplantation
|
Indexed keywords
CARRAGEENAN;
COLCHICINE;
COLCHICINE DERIVATIVE;
CYCLOSPORIN A;
IMMUNOSUPPRESSIVE AGENT;
ZYMOSAN;
ANIMAL CELL;
ANIMAL EXPERIMENT;
AREA UNDER THE CURVE;
ARTHRITIS;
ARTICLE;
B LYMPHOCYTE;
CONTROLLED STUDY;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DESIGN;
DRUG DISTRIBUTION;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG METABOLISM;
DRUG POTENCY;
DRUG SOLUBILITY;
DRUG SYNTHESIS;
IC 50;
IMMUNOASSAY;
IMMUNOMODULATION;
IN VITRO STUDY;
IN VIVO STUDY;
LOCAL LYMPH NODE ASSASY;
LYMPH NODE;
LYMPHOCYTE PROLIFERATION;
MAXIMUM PLASMA CONCENTRATION;
MIXED LYMPHOCYTE REACTION;
MOUSE;
NONHUMAN;
PAW EDEMA;
PHARMACOLOGICAL PARAMETERS;
STEREOCHEMISTRY;
STRUCTURE ACTIVITY RELATION;
T LYMPHOCYTE;
TIME TO MAXIMUM PLASMA CONCENTRATION;
ADMINISTRATION, ORAL;
ANIMALS;
ARTHRITIS;
BIOLOGICAL AVAILABILITY;
COLCHICINE;
DISEASE MODELS, ANIMAL;
IMMUNOSUPPRESSIVE AGENTS;
INHIBITORY CONCENTRATION 50;
MICE;
MICE, INBRED BALB C;
MOLECULAR STRUCTURE;
MUS;
|
EID: 84867573907
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2012.08.068 Document Type: Article |
Times cited : (2)
|
References (28)
|